IBD-OWDI: Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease

Sponsor
Corporacion Parc Tauli (Other)
Overall Status
Unknown status
CT.gov ID
NCT03872726
Collaborator
(none)
800
1
3
270.6

Study Details

Study Description

Brief Summary

Background theme Crohn's disease (CD) and ulcerative colitis (UC) are chronic diseases that alternate flares of active inflammation with periods of clinical remission. The working capacity of patients may be affected both by disease activity and by the aggressive treatment or surgical intervention required for the management of the disease and its complications. Work disability and impairment are especially important in patients with inflammatory bowel disease (IBD) because the disease affects young individuals who are generally employed and fully active.

Although there are several indexes in the literature that assess the degree of work disability due to IBD, all have a high degree of subjectivity, so none can be used to request disability pensions.

Experience of the research group on the subject Our group has developed a line of research on work disability associated with IBD.

Initially the investigators have studied the parameters that condition the granting of disability pensions of Spanish courts.

Subsequently, a population study of the prevalence of work disability in Spain has been carried out.

Finally, the investigators develop and validated a disability index for CD (published in its extensive and reduced form) and for UC (currently under review).

Hypothesis The IBD generates a work disability that can be measured objectively. Establishing the parameters related to disability is essential to promote equity in administrative and judicial decisions related to the granting of disability pensions to patients with IBD.

Objective Development and validation of an objective index to measure the degree of disability in IBD.

Material and methods:
Study 1:

A self-reported and objective questionnaire of disability will be developed based on the data of the population survey already carried out by our group.

Patients from a previous study (n 293) will be included. The relationship of different objective variables and disability outcomes will be analyzed with a univariate and a subsequent multivariate analysis. Alternative work disability scores will be developed.

Study 2: for the validation of the questionnaire a new online interview will be performed, patients from patients' assocations will be asked to participate. Data Collection: patients will answer a online survey administered with the SurveyMonkey © platform.

Participant will answer questions about demographics, disease activity, treatment and complications and data regarding disability. Patients will also complete the SCDWDQ (Short Crohn's Disease Work Disability Questionnaire), Work Productivity and Activity Index (WPAI), IBDQ-9, the EuroQol and IBD-DI (IBD disability index).

Statistical analysis: psychometric properties of the index will be evaluated:
  1. Convergent validity: the Spearman correlation will be used to correlate the objective disability score with IBD-DI and SCDWDQ.

  2. Discriminant validity: it will be measured by the t-test among patients with different degrees of disability (inactive-active, hospitalization-no hospitalization, surgery-no surgery).

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
800 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease
Actual Study Start Date :
Mar 1, 2019
Anticipated Primary Completion Date :
May 30, 2019
Anticipated Study Completion Date :
May 30, 2019

Outcome Measures

Primary Outcome Measures

  1. Development and validation of a self-reported objective index of disability in inflammatory bowel disease [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients between 18 and 65 years old.

  • Labor assets or temporary sick leave.

  • Diagnosis of IBD in the 6 months prior to the survey

Exclusion Criteria:
  • Inability to understand or fill out the questionnaires.

  • Refusal to participate in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Luigi Melcarne Sabadell Barcelona Spain 08208

Sponsors and Collaborators

  • Corporacion Parc Tauli

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Luigi Melcarne, Principal Investigator, Corporacion Parc Tauli
ClinicalTrials.gov Identifier:
NCT03872726
Other Study ID Numbers:
  • Ref.: 2019/523
First Posted:
Mar 13, 2019
Last Update Posted:
Mar 14, 2019
Last Verified:
Mar 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Luigi Melcarne, Principal Investigator, Corporacion Parc Tauli
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2019